{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:48:24Z","timestamp":1793026104072,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T00:00:00Z","timestamp":1174262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T00:00:00Z","timestamp":1174262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2007,8,16]]},"DOI":"10.1038\/sj.onc.1210350","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T08:54:02Z","timestamp":1174294442000},"page":"5635-5642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of novel cell cycle inhibitors in mantle cell lymphoma"],"prefix":"10.1038","volume":"26","author":[{"given":"I-W","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M V R","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E P","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Groopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,19]]},"reference":[{"key":"BF1210350_CR1","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1182\/blood.V84.8.2726.2726","volume":"84","author":"F Bosch","year":"1994","unstructured":"Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N et al. (1994). PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative discoders: a highly specified marker of mantle cell lymphoma. Blood 84: 2725\u20132732.","journal-title":"Blood"},{"key":"BF1210350_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.yexcr.2005.07.009","volume":"310","author":"R Boutros","year":"2005","unstructured":"Boutros R, Byrne JA . (2005). D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells. Exp Cell Res 310: 152\u2013162.","journal-title":"Exp Cell Res"},{"key":"BF1210350_CR3","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1128\/MCB.25.23.10543-10555.2005","volume":"25","author":"SC Braday","year":"2005","unstructured":"Braday SC, Allan LA, Clarke PR . (2005). Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress. Mol Cell Biol 25: 10543\u201310555.","journal-title":"Mol Cell Biol"},{"key":"BF1210350_CR4","first-page":"4197","volume":"25","author":"SC Brauns","year":"2005","unstructured":"Brauns SC, Dealtry G, Milne P, Naude R, Van de Venter M . (2005). Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells. Anticancer Res 25: 4197\u20134202.","journal-title":"Anticancer Res"},{"key":"BF1210350_CR5","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES . (1999). Mantle cell lymphoma. Semin Hematol 36: 115\u2013127.","journal-title":"Semin Hematol"},{"key":"BF1210350_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","volume":"95","author":"R Chiarle","year":"2000","unstructured":"Chiarle R, Budel LM, Skolnik J, Fizzera G, Chilosi M, Corato A et al. (2000). Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95: 619\u2013626.","journal-title":"Blood"},{"key":"BF1210350_CR7","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1158\/0008-5472.CAN-04-3616","volume":"65","author":"S Choi","year":"2005","unstructured":"Choi S, Singh SV . (2005). Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res 65: 2035\u20132043.","journal-title":"Cancer Res"},{"key":"BF1210350_CR8","first-page":"15","volume":"21","author":"DL Crowe","year":"2005","unstructured":"Crowe DL, Sinha UK . (2005). P53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Head Neck 21: 15\u201323.","journal-title":"Head Neck"},{"key":"BF1210350_CR9","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1128\/MCB.25.8.3364-3387.2005","volume":"25","author":"BC Dash","year":"2005","unstructured":"Dash BC, El-Deiry WS . (2005). Phosphorylation of p21 in G2\/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 25: 3364\u20133387.","journal-title":"Mol Cell Biol"},{"key":"BF1210350_CR10","first-page":"1833","volume":"10","author":"CJ de Boer","year":"1995","unstructured":"de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E . (1995). Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10: 1833\u20131840.","journal-title":"Oncogene"},{"key":"BF1210350_CR11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/hmg\/ddh195","volume":"13","author":"RJ de Leeuw","year":"2004","unstructured":"de Leeuw RJ, Davies JJ, Rosenwals A, Bbb G, Gascoyne RD, Dyer MJS et al. (2004). Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genetics 13: 1827\u20131837.","journal-title":"Hum Mol Genetics"},{"key":"BF1210350_CR12","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/sj.onc.1208488","volume":"24","author":"B Elias","year":"2005","unstructured":"Elias B, Laine A, Ronai Z . (2005). Phosphorylation of MdmX by CDK2\/Cdc2(p34) is required for nuclear export of Mdm2. Oncogene 24: 2574\u20132579.","journal-title":"Oncogene"},{"key":"BF1210350_CR13","doi-asserted-by":"publisher","first-page":"11345","DOI":"10.1158\/0008-5472.CAN-05-2159","volume":"15","author":"S Ely","year":"2005","unstructured":"Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN et al. (2005). Mutually exclusive cyclin-dependent kinase 4\/cyclin d1 and cyclin-dependent kinase 6\/cyclin d2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Res 15: 11345\u201311353.","journal-title":"Cancer Res"},{"key":"BF1210350_CR14","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","volume":"23","author":"V Ferbabdez","year":"2005","unstructured":"Ferbabdez V, Hartmann E, Ott G, Campo E, Rosenwald A . (2005). Pathogenesis of mantle-cell lymphoma: All oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Onc 23: 6364\u20136369.","journal-title":"J Clin Onc"},{"key":"BF1210350_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2443.2005.00866.x","volume":"10","author":"T Fukuda","year":"2005","unstructured":"Fukuda T, Asai N, Enomoto A, Takahashi M . (2005). Activation of c-Jun amino-terminal kinase by GDNF induces G2\/M cell cycle delay linked with actin reorganization. Genes Cells 10: 655\u2013663.","journal-title":"Genes Cells"},{"key":"BF1210350_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ccr.2005.02.009","volume":"7","author":"K Gumireddy","year":"2005","unstructured":"Gumireddy K, Pamana Reddy MV, Cosenza SC, Boominathan R, Baker SJ, Papathi N et al. (2005). ON01910, a non-ATP-competitive small molecule inhibitor of PIK1, is a potent anticancer agent. Cancer Cell 7: 275\u2013286.","journal-title":"Cancer Cell"},{"key":"BF1210350_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","volume":"79","author":"T Hunter","year":"1994","unstructured":"Hunter T, Pines J . (1994). Cyclins and cancer: II. Cyclin D and CDK inhibitors come of age. Cell 79: 573\u2013582.","journal-title":"Cell"},{"key":"BF1210350_CR18","doi-asserted-by":"crossref","unstructured":"Kimby E, Wallblom A, Sander B . (2005). Mantle cell lymphoma: Chromosomal aberrations, proliferation and cyclin D1 transcripts in relation to clinical outcome. Annals of Oncology 9th International Conference on Malignant Lymphoma 16 (Supplement 5): v168 (#446).","DOI":"10.1093\/annonc\/mdi579"},{"key":"BF1210350_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cell.2004.07.025","volume":"118","author":"K Kozar","year":"2004","unstructured":"Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E . (2004). Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477\u2013491.","journal-title":"Cell"},{"key":"BF1210350_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/00000478-199008000-00007","volume":"14","author":"P Lardelli","year":"1990","unstructured":"Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES . (1990). Lymphocytic lymphoma of intermediate differentiation: morphologic and immunophenotypic spectrum and clinical correlation. Am J Surg Pathol 14: 752\u2013763.","journal-title":"Am J Surg Pathol"},{"key":"BF1210350_CR21","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1073\/pnas.051629198","volume":"98","author":"KH Lee","year":"2001","unstructured":"Lee KH, Rudolph KL, Ju YJ, Greenberg RA, Cannizzaro L, Chin L et al. (2001). Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Pro Natl Acad Sci USA 98: 3381\u20133386.","journal-title":"Pro Natl Acad Sci USA"},{"key":"BF1210350_CR22","first-page":"100657","volume":"65","author":"SA Martin","year":"2005","unstructured":"Martin SA, Ouchi T . (2005). BRCA1 phosphorylation regulates caspase-3 activation in UV-induced apoptosis. Cancer Res 65: 100657\u2013100662.","journal-title":"Cancer Res"},{"key":"BF1210350_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0076-6879(97)83017-0","volume":"283","author":"JR Nevins","year":"1997","unstructured":"Nevins JR, DeGregori J, Jakoi L, Leone G . (1997). Functional analysis of E2F transcription factor. Methods Enzymol 283: 205\u2013219.","journal-title":"Methods Enzymol"},{"key":"BF1210350_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00432-004-0607-2","volume":"131","author":"T Nozoe","year":"2005","unstructured":"Nozoe T, Takahashi I, Baba H, Maehara Y . (2005). Relationship between intracellular localization of p34cdc2 protein and differentiation of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 131: 179\u2013183.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF1210350_CR25","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.4049\/jimmunol.167.5.2766","volume":"167","author":"IW Park","year":"2001","unstructured":"Park IW, Ulrich CK, Schoenberger E, Ganju RK, Groopman JE . (2001). HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 167: 2766\u20132771.","journal-title":"J Immunol"},{"key":"BF1210350_CR26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK et al. (2005). Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGF-beta signaling pathways. Br J Haematol 130: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BF1210350_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. (2003). The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3: 185\u2013197.","journal-title":"Cancer Cell"},{"key":"BF1210350_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D . (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature (London) 366: 704\u2013707.","journal-title":"Nature (London)"},{"key":"BF1210350_CR29","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr CJ, Roberts JM . (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501\u20131512.","journal-title":"Genes Dev"},{"key":"BF1210350_CR30","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1101\/gad.1256504","volume":"18","author":"CJ Sherr","year":"2004","unstructured":"Sherr CJ, Roberts JM . (2004). Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699\u20132711.","journal-title":"Genes Dev"},{"key":"BF1210350_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/hupa.2002.30221","volume":"33","author":"SH Swerdlow","year":"2002","unstructured":"Swerdlow SH, Williams ME . (2002). From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 33: 7\u201320.","journal-title":"Hum Pathol"},{"key":"BF1210350_CR32","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1158\/0008-5472.CAN-05-1226","volume":"65","author":"J Tan","year":"2005","unstructured":"Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET, Yu Q . (2005). Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cell. Cancer Res 65: 9012\u20139020.","journal-title":"Cancer Res"},{"key":"BF1210350_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Lkapper W, Dreyling MH, Campo E, Norton A et al. (2005). Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell clymphoma (MCL): a clinicopathological study form the European MCL Network. Br J Haematol 131: 29\u201338.","journal-title":"Br J Haematol"},{"key":"BF1210350_CR34","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE . (2005). Current treatment approaches for mantle-cell lymphoma. J Clin Onc 23: 6409\u20136414.","journal-title":"J Clin Onc"},{"key":"BF1210350_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-540-69686-5_9","volume":"22","author":"L Yamasaki","year":"1998","unstructured":"Yamasaki L . (1998). Growth regulation by the E2F and DP transcription factor families. Results Probl Cell Differ 22: 199\u2013227.","journal-title":"Results Probl Cell Differ"},{"key":"BF1210350_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","volume":"6","author":"E Zucca","year":"1995","unstructured":"Zucca E, Roggero E, Pinotti G, Pedrinis E, Capella C, Venco A et al. (1995). Patterns of survival in mantle cell lymphoma. Ann Oncol 6: 257\u2013262.","journal-title":"Ann Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210350","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:35:53Z","timestamp":1647945353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,19]]},"references-count":36,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2007,8,16]]}},"alternative-id":["BF1210350"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210350","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,19]]},"assertion":[{"value":"2 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}